Cystic fibrosis-related diabetes testing in Toscolano-Maderno

Find health labs to test for Cystic fibrosis-related diabetes in Toscolano-Maderno and compare all offers by prices and services.

Tests that cover Cystic fibrosis-related diabetes

Diabetes Test
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€35.00

€33.25 with our promocode

See Details

Hemoglobin Test by Farmacia Manganelli

Via degli Alpini, 2, 24064 Grumello del Monte BG, Italia

35.6 km

Unverified

See Details

Diabetes Test by Synlab

Via Sorte, 48, 37047 San Bonifacio VR, Italia

36.3 km

Unverified

See Details

Hemoglobin Test by Casa della Salute

Via Cesare Battisti, 99, 38042 Baselga di Pinè TN, Italia

45.6 km

Unverified

See Details

Hemoglobin Test by Lab - Analisi Cliniche

Via Paolo Borsellino, 1, 26865 San Rocco al Porto LO, Italia

58.7 km

Unverified

See Details

Diabetes Test by Gemini Srl - Poliambulatorio a Parma

Piazza Sisto Rosa Badalocchio, 3, 43126 Parma PR, Italia

59.6 km

Unverified

See Details

Hemoglobin Test by Synlab Euganea Medica

Via Cristoforo Colombo, 13, 35020 Albignasego PD, Italia

64.4 km

Unverified

See Details

Hemoglobin Test by Synlab

Via Antonio Zanchi, 89, 35133 Padova PD, Italia

63.6 km

Unverified

See Details

Hemoglobin Test by Synlab

Via Giovanni Boccaccio, 106, 35128 Padova PD, Italia

63.6 km

Unverified

See Details

Hemoglobin Test by Farmacia Di Paina Di Taborelli Dr. Angelo

Viale Brianza, 14, 20833 Giussano MB, Italia

67.8 km

Unverified

See Details

Diabetes Test by Farmacia Vitruvio

Via Vitruvio, 39, 20124 Milano MI, Italia

69.6 km

Unverified

See Details

Cystic fibrosis-related diabetes - symptoms and how to test

Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.